Marketability is the competitive positioning of brands, products, or services to markets. In other words, the possibility of product sales and risk not being sold. The following is general marketability.
Be able to provide reasonable prices and profits at this level. In the product industry, prices are determined by the market, higher cost base is an important competitive disadvantage. Quality competition of high quality products against perceived quality
Competitive characteristics and performance when compared with other products on the market. Innovative or niche products may offer their own functions. In some cases, lack of functionality may be advantageous if customer needs and preferences are offered.
Value of products offered to customers such as reliability, durability, ease of use, customer experience, design etc.
In fact, the input type will depend on the application type, market, and delivery method. It is like raw material. Consider, for example, water markets such as drinking, cleaning, oil and gas recovery, agriculture, manufacturing, entertainment, hydraulic power. Water is an input type, its use includes many industries and use cases. When considering the total value of water you can not just judge the size of the packaged beverage market You need to see the usefulness of the water in all industries. The same thing is expected to occur also in AI. Rather than considering the vertical market potential, you should consider using input types in all market segments.
The world market value of age-related macular degeneration in 2015 is $ 53.357 billion, the combined annual growth rate is expected to be 6% between 2016 and 2022. Among various types, wet AMD fragments are expected to grow faster than dry AMD fragments during the prediction period. The worldwide age-related macular degeneration market grows at a considerable rate due to the increase in medical expenses, the spread of lifestyle diseases such as obesity and high blood pressure. In addition, the increase in elderly population, the prevalence of AMD, and the increase in AMD pipeline drugs also contribute to the growth of the worldwide age-related macular degeneration market.
There are two types of AMD: dry (atrophic) and wet (neurovascular or exudative). Most AMDs start with dry type and develop into wet type with 10 to 20% of individuals. Age-related macular degeneration is always bilateral (that is, occurs in both eyes), but it does not necessarily proceed at the same rate in both eyes. Therefore, it may be wet with one eye and dry with the other eye. About 80 to 90% of AMD patients suffer from dry type (atrophic type). The reason for this is unclear, and it tends to proceed at a slower rate at moisture and is not yet approved for treatment or treatment. In dry age-related macular degeneration, a small white or yellowish deposit called drusen is formed on the retina under the macula and deteriorates or worsens with the passage of time.